The anisotropic λ -deformed SU(2) model is integrable

The all-loop anisotropic Thirring model interpolates between the WZW model and the non-Abelian T-dual of the anisotropic principal chiral model. We focus on the SU(2) case and we prove that it is classically integrable by providing its Lax pair formulation. We derive its underlying symmetry current algebra and use it to show that the Poisson brackets of the spatial part of the Lax pair, assume the Maillet form. In this way we procure the corresponding r and s matrices which provide non-trivial solutions to the modified Yang–Baxter equation.

Poorly controlled type 2 diabetes mellitus is associated with a decreased risk of incident gout: a population-based case-control study

OBJECTIVE The aim of this study was to explore the risk of incident gout in patients with type 2 diabetes mellitus (T2DM) in association with diabetes duration, diabetes severity and antidiabetic drug treatment. METHODS We conducted a case-control study in patients with T2DM using the UK-based Clinical Practice Research Datalink (CPRD). We identified case patients aged ≥18 years with an incident diagnosis of gout between 1990 and 2012. We matched to each case patient one gout-free control patient. We used conditional logistic regression analysis to calculate adjusted ORs (adj. ORs) with 95% CIs and adjusted our analyses for important potential confounders. RESULTS The study encompassed 7536 T2DM cases with a first-time diagnosis of gout. Compared to a diabetes duration <1 year, prolonged diabetes duration (1-3, 3-6, 7-9 and ≥10 years) was associated with decreased adj. ORs of 0.91 (95% CI 0.79 to 1.04), 0.76 (95% CI 0.67 to 0.86), 0.70 (95% CI 0.61 to 0.86), and 0.58 (95% CI 0.51 to 0.66), respectively. Compared to a reference A1C level of <7%, the risk estimates of increasing A1C levels (7.0-7.9, 8.0-8.9 and ≥9%) steadily decreased with adj. ORs of 0.79 (95% CI 0.72 to 0.86), 0.63 (95% CI 0.55 to 0.72), and 0.46 (95% CI 0.40 to 0.53), respectively. Neither use of insulin, metformin, nor sulfonylureas was associated with an altered risk of incident gout. CONCLUSIONS Increased A1C levels, but not use of antidiabetic drugs, was associated with a decreased risk of incident gout among patients with T2DM.

Treatment intensification with insulin glargine in patients with inadequately controlled type 2 diabetes improves glycaemic control with a high treatment satisfaction and no weight gain

PRINCIPLES We aimed to evaluate the efficacy of, and treatment satisfaction with, insulin glargine administered with SoloSTAR® or ClikSTAR® pens in patients with type 2 diabetes mellitus managed by primary care physicians in Switzerland. METHODS A total of 327 patients with inadequately controlled type 2 diabetes were enrolled by 72 physicians in this prospective observational study, which aimed to evaluate the efficacy of a 6-month course of insulin glargine therapy measured as development of glycaemic control (glycosylated haemoglobin [HbA1c] and fasting plasma glucose [FPG]) and weight change. We also assessed preference for reusable or disposable pens, and treatment satisfaction. RESULTS After 6 months, the mean daily dose of insulin glargine was 27.7±14.3 U, and dose titration was completed in 228 (72.4%) patients. Mean HbA1c decreased from 8.9%±1.6% (n=327) to 7.3%±1.0% (n=315) (p<0.0001), and 138 (43.8%) patients achieved an HbA1c≤7.0%. Mean FPG decreased from 10.9±4.5 to 7.3±1.8 mmol/l (p<0.0001). Mean body weight did not change (85.4±17.2 kg vs 85.0±16.5 kg; p=0.11). Patients' preference was in favour of the disposable SoloStar® pen (80%), as compared with the reusable ClickStar® pen (20%). Overall, 92.6% of physicians and 96.3% of patients were satisfied or very satisfied with the insulin glargine therapy. CONCLUSIONS In patients with type 2 diabetes insulin glargine administered by SoloSTAR® or ClikSTAR® pens, education on insulin injection and on self-management of diabetes was associated with clinically meaningful improvements in HbA1c and FPG without a mean collective weight gain. The vast majority of both patients and primary care physicians were satisfied with the treatment intensification.

Concomitant Mycobacterium tuberculosis infection and type 2 diabetes: A descriptive model with global health implications

The type 2 diabetes (diabetes) pandemic is recognized as a threat to tuberculosis (TB) control worldwide. This secondary data analysis project estimated the contribution of diabetes to TB in a binational community on the Texas-Mexico border where both diseases occur. Newly-diagnosed TB patients > 20 years of age were prospectively enrolled at Texas-Mexico border clinics between January 2006 and November 2008. Upon enrollment, information regarding social, demographic, and medical risks for TB was collected at interview, including self-reported diabetes. In addition, self-reported diabetes was supported by blood-confirmation according to guidelines published by the American Diabetes Association (ADA). For this project, data was compared to existing statistics for TB incidence and diabetes prevalence from the corresponding general populations of each study site to estimate the relative and attributable risks of diabetes to TB. In concordance with historical sociodemographic data provided for TB patients with self-reported diabetes, our TB patients with diabetes also lacked the risk factors traditionally associated with TB (alcohol abuse, drug abuse, history of incarceration, and HIV infection); instead, the majority of our TB patients with diabetes were characterized by overweight/obesity, chronic hyperglycemia, and older median age. In addition, diabetes prevalence among our TB patients was significantly higher than in the corresponding general populations. Findings of this study will help accurately characterize TB patients with diabetes, thus aiding in the timely recognition and diagnosis of TB in a population not traditionally viewed as at-risk. We provide epidemiological and biological evidence that diabetes continues to be an increasingly important risk factor for TB.^

(Table 2) Correlation of Mi zones with hiatuses in ODP Site 181-1124

Results from Ocean Drilling Program sites 1121-1124 show the Eastern New Zealand Oceanic Sedimentary System (ENZOSS) evolved in response to: (1) the inception of the circum-Antarctic circulation, (2) orbital and nonorbital regulation of the global thermohaline flow, and (3) development of the New Zealand plate boundary. ENZOSS began in the early Oligocene following opening of the Tasmanian gateway and inception of the ancestral Antarctic Circumpolar Current (ACC) and SW Pacific Deep Western Boundary Current (DWBC). Widespread erosion, marked by the Marshall Paraconformity, was followed by extensive drift formation in the late Oligocene- early Miocene. Alternating nannofossil chalk and nannofossil-rich mud deposited in response to 41-kyr orbital regulation of the abyssal circulation, with the mudstones representing times of increased inflow of corrosive southernsource waters. Drift deposition at the deepest sites was interrupted by bouts of erosion coincident with Mi 1-5 isotopic events signifying expansions of the East Antarctic Ice Sheet and enhanced bottom water formation. By late Miocene times, the basic ENZOSS was established. South of Bounty Trough, the energetic ACC instigated an erosional/low depositional regime. To the north, where the DWBC prevailed, orbitally regulated drift deposition continued. Increased convergence at the New Zealand plate boundary enhanced the terrigenous supply, but little of this sediment reached the deep ENZOSS as the three main sediment conduits - Solander, Bounty and Hikurangi channels - had not fully developed. The Plio-Pleistocene heralded a change from a carbonate- to terrigenous-dominant supply caused by interception of the DWBC by the three channels (~1.6 Ma for Bounty and Hikurangi, time of Solander interception unknown). The Solander and Bounty fans, and Hikurangi Fan-drift systems formed, and drifts downstream of those systems, received terrigenous detritus. Supply increased with accelerating uplift along the plate boundary, but delivery to the DWBC was regulated by eustatic fluctuations of sea level. Times of maximum supply to all three channels was during glacial lowstands whereas the supply either ceased (Bounty, Solander), or reduced (Hikurangi) in highstands. In glacial times, sediment was entrained by a DWBC invigorated by an increased input of Antarctic bottom water. The ACC also accelerated under strengthened glacial winds. Thus, glacials were times of optimum sediment supply to ENZOSS depocentres where depositional rates were 2-3 times more than interglacial rates.